Cargando…
Insights into Newer Antimicrobial Agents Against Gram-negative Bacteria
Currently, drug resistance, especially against cephalosporins and carbapenems, among gram-negative bacteria is an important challenge, which is further enhanced by the limited availability of drugs against these bugs. There are certain antibiotics (colistin, fosfomycin, temocillin, and rifampicin) t...
Autores principales: | Taneja, Neelam, Kaur, Harsimran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803319/ https://www.ncbi.nlm.nih.gov/pubmed/27013887 http://dx.doi.org/10.4137/MBI.S29459 |
Ejemplares similares
-
Use of Newer and Repurposed Antibiotics against Gram-Negative Bacteria in Neonates
por: Kontou, Angeliki, et al.
Publicado: (2023) -
In Vitro Activity of Newer and Conventional Antimicrobial Agents, Including Fosfomycin and Colistin, against Selected Gram-Negative Bacilli in Kuwait
por: Alfouzan, Wadha, et al.
Publicado: (2018) -
Bloodstream Infection and Gram-Negative Resistance: The Role for Newer Antibiotics
por: Waters, Jessica, et al.
Publicado: (2023) -
Motuporamine Derivatives as Antimicrobial Agents and Antibiotic Enhancers against Resistant Gram‐Negative Bacteria
por: Borselli, Diane, et al.
Publicado: (2017) -
Novel Antimicrobial Agents for Gram-Negative Pathogens
por: Karvouniaris, Marios, et al.
Publicado: (2023)